GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Orbotech Ltd. (ORBK) [hlAlert]

Rating:
Buy ORBK
up 3.67 %

Orbotech Ltd. (ORBK) rated Buy by Standpoint Research

Posted on: Wednesday,  Apr 1, 2015  12:25 PM ET by Standpoint Research

Standpoint Research rated Buy Orbotech Ltd. (NASDAQ: ORBK) on 04/01/2015, when the stock price was $16.05. Since
then, Orbotech Ltd. has gained 3.68% as of 01/05/2016's recent price of $16.64.
If you would have followed this Standpoint Research's recommendation on ORBK, you would have gained 3.67% of your investment in 279 days.

Orbotech Ltd., is principally engaged in the design, development, manufacture, marketing and service of yield-enhancing and production solutions for specialized applications in the supply chain of the electronics industry. The Company?s products include automated optical inspection (AOI) and process control systems for bare and assembled printed circuit boards (PCBs) and for flat panel displays (FPDs), and imaging solutions for PCB production. It also markets computer-aided manufacturing and engineering (CAM) solutions for PCB production. The Company, through its subsidiary, Orbograph Ltd. (Orbograph), it develops and markets automatic check reading solutions to banks and other financial institutions, and has developed a technology for Web-based, location-independent data entry for check processing and forms processing; and, through its subsidiary Orbotech Medical Solutions Ltd.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/1/2015 12:25 PM Buy
None
16.05
as of 8/27/2015
1 Week down  -7.70 %
1 Month down  -23.59 %
3 Months down  -10.96 %
1 YTD up  3.67 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy